Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy

23 Dec 2016

Abstract excerpt

BACKGROUND: This study aimed to determine the frequency of transactive response DNA binding protein 43 kDa pathology in PSP, the clinical features of patients with this pathology, and genetic risk factors for it. METHODS: Hippocampal sections were screened with immunohistochemistry for transactive response DNA binding protein 43 kDa in 945 PSP cases. A subset of 261 cases that were negative in hippocampus was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amyotrophic Lateral Sclerosis Research
Share to Genetic Neurodegenerative Diseases
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28009087
DOI: 10.1002/mds.26809

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 9 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsyPMID 28009087Read ↗

Progressive supranuclear palsy: a systematic review.Semantic proximity Read ↗

Neuropathology of variants of progressive supranuclear palsy.Semantic proximity Read ↗

Amyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases.Semantic proximity Read ↗

CSF Proteomics in Patients With Progressive Supranuclear PalsySemantic proximity Read ↗

The diagnosis of progressive supranuclear palsy: current opinions and challenges.Semantic proximity Read ↗

Progressive supranuclear palsy: current approach and challenges to diagnosis and treatment.Semantic proximity Read ↗

Novel Therapeutic Targets and Biomarkers for the Treatment of Progressive Supranuclear PalsySemantic proximity Read ↗

Progressive supranuclear palsy (PSP): Richardson syndrome and other PSP variants.Semantic proximity Read ↗

Pathological hallmarks of amyotrophic lateral sclerosis/frontotemporal lobar degeneration in transgenic mice produced with TDP-43 genomic fragmentsSemantic proximity Read ↗

Review: Transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegenerationSemantic proximity Read ↗

Progressive Supranuclear Palsy: an Update.Semantic proximity Read ↗

The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.